Back

Levosimendan abrogates early stage and progressive arrhythmogenic right ventricular cardiomyopathy in desmin null mice

26 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Cardiac arrhythmias Cardiomyopathies ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Efstathios Iliodromitis

National & Kapodistrian University of Athens Medical School, Athens (Greece)

9 More presentations in this session

Presentation thumbnail
Doctor M. Kostyukevich (Moscow, RU)
Abstract
Presentation thumbnail
Doctor K. Ito (Tokorozawa, JP)
Abstract Slides
Presentation thumbnail
Professor S. Lebek (Regensburg, DE)
Abstract
Presentation thumbnail
Doctor U. Gulan (Zurich, CH)
Abstract
Presentation thumbnail
Mr R. Quinonez Uribe (Goettingen, DE)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - Cardiac arrhythmias

The Event

Event poster

ESC Congress 2018

26 August 2018 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Insights from the contemporary use of levosimendan in a tertiary cardiology centre
20 May 2023
thumbnail
Congress Presentation
The impact of desmosomal mutations on clinical features in arrhythmogenic cardiomyopathy: towards tailored arrhythmic risk stratification
1 September 2025
thumbnail
Congress Presentation
Gain-of-function vs. loss-of-function effects of DES variants on cardiodesminopathy phenotypes
1 September 2025
thumbnail
Congress Presentation
New therapeutic strategy targeting regulation of the SERCA2 complex protects from myocardial ischemia-reperfusion injury
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources